US Stock MarketDetailed Quotes

VYNE VYNE Therapeutics

Watchlist
  • 2.9600
  • +0.0100+0.34%
Close Nov 29 13:00 ET
  • 2.9600
  • 0.00000.00%
Post 17:01 ET
43.66MMarket Cap0.87P/E (TTM)

VYNE Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
6.14%121K
46.67%198K
-1.01%98K
-11.11%424K
1,166.67%76K
-31.74%114K
7.14%135K
-44.38%99K
-48.76%477K
-97.80%6K
Operating revenue
6.14%121K
46.67%198K
-1.01%98K
-11.11%424K
1,166.67%76K
-31.74%114K
7.14%135K
-44.38%99K
-48.76%477K
-97.80%6K
Cost of revenue
Gross profit
Operating expense
108.13%13.21M
1.35%10.59M
25.18%7.48M
-14.64%29.68M
-13.54%6.91M
-33.18%6.35M
24.25%10.45M
-32.64%5.97M
-12.73%34.77M
-12.38%7.99M
Selling and administrative expenses
-2.18%2.96M
2.11%3.29M
16.36%3.77M
-18.38%13.38M
4.69%3.89M
-23.37%3.03M
-25.20%3.22M
-26.65%3.24M
-19.27%16.39M
-22.61%3.71M
-General and administrative expense
-2.18%2.96M
2.11%3.29M
16.36%3.77M
-18.38%13.38M
--3.89M
--3.03M
--3.22M
--3.24M
--16.39M
----
Research and development costs
208.86%10.25M
1.01%7.31M
35.63%3.71M
-11.30%16.31M
-29.35%3.02M
-40.17%3.32M
76.07%7.23M
-38.59%2.73M
-5.93%18.39M
-1.04%4.28M
Operating profit
-109.99%-13.09M
-0.76%-10.4M
-25.62%-7.38M
14.69%-29.26M
14.43%-6.83M
33.20%-6.23M
-24.51%-10.32M
32.40%-5.88M
11.86%-34.3M
9.74%-7.98M
Net non-operating interest income expense
Other net income (expense)
473.01%934K
257.50%1M
333.08%1.14M
281.82%1.39M
188.14%680K
108.97%163K
438.46%280K
8,866.67%263K
368.89%363K
807.69%236K
Other non- operating income (expenses)
473.01%934K
257.50%1M
333.08%1.14M
281.82%1.39M
188.14%680K
108.97%163K
438.46%280K
8,866.67%263K
368.89%363K
807.69%236K
Income before tax
-100.25%-12.16M
6.41%-9.4M
-11.21%-6.24M
17.86%-27.87M
20.60%-6.15M
34.40%-6.07M
-21.89%-10.04M
35.45%-5.61M
24.01%-33.93M
12.15%-7.75M
Income tax
0
0
0
0
0
0
0
0
102.90%13K
102.90%13K
Net income
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
-22.59%-28.45M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
68.35%-23.21M
14.04%-9.95M
Net income continuous Operations
-100.25%-12.16M
6.41%-9.4M
-11.21%-6.24M
17.89%-27.87M
20.73%-6.15M
34.40%-6.07M
-21.89%-10.04M
35.45%-5.61M
23.22%-33.95M
7.30%-7.76M
Net income discontinuous operations
--0
45.00%-11K
20.00%-8K
-105.40%-580K
98.35%-36K
-151.47%-513K
91.70%-20K
-100.07%-10K
136.86%10.74M
31.71%-2.18M
Minority interest income
Net income attributable to the parent company
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
-22.59%-28.45M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
68.35%-23.21M
14.04%-9.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-84.64%-12.16M
6.48%-9.41M
-11.15%-6.25M
-22.59%-28.45M
37.78%-6.19M
30.39%-6.58M
-18.66%-10.06M
-220.39%-5.62M
68.35%-23.21M
14.04%-9.95M
Basic earnings per share
85.57%-0.29
92.88%-0.22
91.38%-0.15
61.81%-2.78
86.82%-0.4389
31.63%-2.01
-17.49%-3.09
-215.23%-1.74
71.61%-7.28
15.91%-3.33
Diluted earnings per share
85.57%-0.29
92.88%-0.22
91.38%-0.15
61.81%-2.78
86.82%-0.4389
31.63%-2.01
-17.49%-3.09
-215.23%-1.74
71.61%-7.28
15.91%-3.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 6.14%121K 46.67%198K -1.01%98K -11.11%424K 1,166.67%76K -31.74%114K 7.14%135K -44.38%99K -48.76%477K -97.80%6K
Operating revenue 6.14%121K 46.67%198K -1.01%98K -11.11%424K 1,166.67%76K -31.74%114K 7.14%135K -44.38%99K -48.76%477K -97.80%6K
Cost of revenue
Gross profit
Operating expense 108.13%13.21M 1.35%10.59M 25.18%7.48M -14.64%29.68M -13.54%6.91M -33.18%6.35M 24.25%10.45M -32.64%5.97M -12.73%34.77M -12.38%7.99M
Selling and administrative expenses -2.18%2.96M 2.11%3.29M 16.36%3.77M -18.38%13.38M 4.69%3.89M -23.37%3.03M -25.20%3.22M -26.65%3.24M -19.27%16.39M -22.61%3.71M
-General and administrative expense -2.18%2.96M 2.11%3.29M 16.36%3.77M -18.38%13.38M --3.89M --3.03M --3.22M --3.24M --16.39M ----
Research and development costs 208.86%10.25M 1.01%7.31M 35.63%3.71M -11.30%16.31M -29.35%3.02M -40.17%3.32M 76.07%7.23M -38.59%2.73M -5.93%18.39M -1.04%4.28M
Operating profit -109.99%-13.09M -0.76%-10.4M -25.62%-7.38M 14.69%-29.26M 14.43%-6.83M 33.20%-6.23M -24.51%-10.32M 32.40%-5.88M 11.86%-34.3M 9.74%-7.98M
Net non-operating interest income expense
Other net income (expense) 473.01%934K 257.50%1M 333.08%1.14M 281.82%1.39M 188.14%680K 108.97%163K 438.46%280K 8,866.67%263K 368.89%363K 807.69%236K
Other non- operating income (expenses) 473.01%934K 257.50%1M 333.08%1.14M 281.82%1.39M 188.14%680K 108.97%163K 438.46%280K 8,866.67%263K 368.89%363K 807.69%236K
Income before tax -100.25%-12.16M 6.41%-9.4M -11.21%-6.24M 17.86%-27.87M 20.60%-6.15M 34.40%-6.07M -21.89%-10.04M 35.45%-5.61M 24.01%-33.93M 12.15%-7.75M
Income tax 0 0 0 0 0 0 0 0 102.90%13K 102.90%13K
Net income -84.64%-12.16M 6.48%-9.41M -11.15%-6.25M -22.59%-28.45M 37.78%-6.19M 30.39%-6.58M -18.66%-10.06M -220.39%-5.62M 68.35%-23.21M 14.04%-9.95M
Net income continuous Operations -100.25%-12.16M 6.41%-9.4M -11.21%-6.24M 17.89%-27.87M 20.73%-6.15M 34.40%-6.07M -21.89%-10.04M 35.45%-5.61M 23.22%-33.95M 7.30%-7.76M
Net income discontinuous operations --0 45.00%-11K 20.00%-8K -105.40%-580K 98.35%-36K -151.47%-513K 91.70%-20K -100.07%-10K 136.86%10.74M 31.71%-2.18M
Minority interest income
Net income attributable to the parent company -84.64%-12.16M 6.48%-9.41M -11.15%-6.25M -22.59%-28.45M 37.78%-6.19M 30.39%-6.58M -18.66%-10.06M -220.39%-5.62M 68.35%-23.21M 14.04%-9.95M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -84.64%-12.16M 6.48%-9.41M -11.15%-6.25M -22.59%-28.45M 37.78%-6.19M 30.39%-6.58M -18.66%-10.06M -220.39%-5.62M 68.35%-23.21M 14.04%-9.95M
Basic earnings per share 85.57%-0.29 92.88%-0.22 91.38%-0.15 61.81%-2.78 86.82%-0.4389 31.63%-2.01 -17.49%-3.09 -215.23%-1.74 71.61%-7.28 15.91%-3.33
Diluted earnings per share 85.57%-0.29 92.88%-0.22 91.38%-0.15 61.81%-2.78 86.82%-0.4389 31.63%-2.01 -17.49%-3.09 -215.23%-1.74 71.61%-7.28 15.91%-3.33
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion with Explanatory Notes --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data